Other

Research and development funding liability (Note 5)

Moderna Research and development funding liability (Note 5) decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2024
Last reportedQ1 2026May 1, 2026
Metric ID: other_research_and_development_liability_current

Historical Data

6 periods
 Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$58.00M$0.00$0.00$0.00$43.00M$0.00
QoQ Change-100.0%-100.0%
YoY Change-25.9%
Range$0.00$58.00M
CAGR-100.0%
Avg YoY Growth-25.9%
Median YoY Growth-25.9%
Current Streak2+ quarters decline

Frequently Asked Questions

What is Moderna's research and development funding liability (note 5)?
Moderna (MRNA) reported research and development funding liability (note 5) of $0.00 in Q1 2026.